Literature DB >> 16885031

Destruction or potentiation of different prions catalyzed by similar Hsp104 remodeling activities.

James Shorter1, Susan Lindquist.   

Abstract

Yeast prions are protein-based genetic elements that self-perpetuate changes in protein conformation and function. A protein-remodeling factor, Hsp104, controls the inheritance of several yeast prions, including those formed by Sup35 and Ure2. Perplexingly, deletion of Hsp104 eliminates Sup35 and Ure2 prions, whereas overexpression of Hsp104 purges cells of Sup35 prions, but not Ure2 prions. Here, we used pure components to dissect how Hsp104 regulates prion formation, growth, and division. For both Sup35 and Ure2, Hsp104 catalyzes de novo prion nucleation from soluble, native protein. Using a distinct mechanism, Hsp104 fragments both prions to generate new prion assembly surfaces. For Sup35, the fragmentation endpoint is an ensemble of noninfectious, amyloid-like aggregates and soluble protein that cannot replicate conformation. In vivid distinction, the endpoint of Ure2 fragmentation is short prion fibers with enhanced infectivity and self-replicating ability. These advances explain the distinct effects of Hsp104 on the inheritance of the two prions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16885031      PMCID: PMC1540446          DOI: 10.1016/j.molcel.2006.05.042

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  44 in total

1.  Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers.

Authors:  James Shorter; Susan Lindquist
Journal:  Science       Date:  2004-05-20       Impact factor: 47.728

2.  Epigenetic regulation of translation reveals hidden genetic variation to produce complex traits.

Authors:  Heather L True; Ilana Berlin; Susan L Lindquist
Journal:  Nature       Date:  2004-08-15       Impact factor: 49.962

3.  Conformational variations in an infectious protein determine prion strain differences.

Authors:  Motomasa Tanaka; Peter Chien; Nariman Naber; Roger Cooke; Jonathan S Weissman
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

4.  Saccharomyces cerevisiae Hsp104 protein. Purification and characterization of ATP-induced structural changes.

Authors:  D A Parsell; A S Kowal; S Lindquist
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

5.  The mechanisms of [URE3] prion elimination demonstrate that large aggregates of Ure2p are dead-end products.

Authors:  Leslie Ripaud; Laurent Maillet; Christophe Cullin
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

6.  The prion curing agent guanidinium chloride specifically inhibits ATP hydrolysis by Hsp104.

Authors:  Valerie Grimminger; Klaus Richter; Axel Imhof; Johannes Buchner; Stefan Walter
Journal:  J Biol Chem       Date:  2003-12-10       Impact factor: 5.157

7.  Global analysis of protein expression in yeast.

Authors:  Sina Ghaemmaghami; Won-Ki Huh; Kiowa Bower; Russell W Howson; Archana Belle; Noah Dephoure; Erin K O'Shea; Jonathan S Weissman
Journal:  Nature       Date:  2003-10-16       Impact factor: 49.962

8.  Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104.

Authors:  Dmitry S Kryndushkin; Ilya M Alexandrov; Michael D Ter-Avanesyan; Vitaly V Kushnirov
Journal:  J Biol Chem       Date:  2003-09-24       Impact factor: 5.157

9.  Protein-only transmission of three yeast prion strains.

Authors:  Chih-Yen King; Ruben Diaz-Avalos
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

10.  A neuronal isoform of the aplysia CPEB has prion-like properties.

Authors:  Kausik Si; Susan Lindquist; Eric R Kandel
Journal:  Cell       Date:  2003-12-26       Impact factor: 41.582

View more
  117 in total

Review 1.  Modulation and elimination of yeast prions by protein chaperones and co-chaperones.

Authors:  Michael Reidy; Daniel C Masison
Journal:  Prion       Date:  2011-10-01       Impact factor: 3.931

Review 2.  Patterns of [PSI (+) ] aggregation allow insights into cellular organization of yeast prion aggregates.

Authors:  Jens Tyedmers
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

Review 3.  Emergence and natural selection of drug-resistant prions.

Authors:  James Shorter
Journal:  Mol Biosyst       Date:  2010-04-27

4.  Mechanistic Insights into Hsp104 Potentiation.

Authors:  Mariana P Torrente; Edward Chuang; Megan M Noll; Meredith E Jackrel; Michelle S Go; James Shorter
Journal:  J Biol Chem       Date:  2016-01-08       Impact factor: 5.157

5.  The Paf1 complex subunit Rtf1 buffers cells against the toxic effects of [PSI+] and defects in Rkr1-dependent protein quality control in Saccharomyces cerevisiae.

Authors:  Kristin M Klucevsek; Mary A Braun; Karen M Arndt
Journal:  Genetics       Date:  2012-05-17       Impact factor: 4.562

6.  Asymmetric deceleration of ClpB or Hsp104 ATPase activity unleashes protein-remodeling activity.

Authors:  Shannon M Doyle; James Shorter; Michal Zolkiewski; Joel R Hoskins; Susan Lindquist; Sue Wickner
Journal:  Nat Struct Mol Biol       Date:  2007-01-28       Impact factor: 15.369

7.  Visualizing the ATPase cycle in a protein disaggregating machine: structural basis for substrate binding by ClpB.

Authors:  Sukyeong Lee; Jae-Mun Choi; Francis T F Tsai
Journal:  Mol Cell       Date:  2007-01-26       Impact factor: 17.970

Review 8.  More than Just a Phase: Prions at the Crossroads of Epigenetic Inheritance and Evolutionary Change.

Authors:  Anupam K Chakravarty; Daniel F Jarosz
Journal:  J Mol Biol       Date:  2018-07-19       Impact factor: 5.469

9.  Specificity of the J-protein Sis1 in the propagation of 3 yeast prions.

Authors:  Takashi Higurashi; Justin K Hines; Chandan Sahi; Rebecca Aron; Elizabeth A Craig
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-27       Impact factor: 11.205

10.  GPI anchoring facilitates propagation and spread of misfolded Sup35 aggregates in mammalian cells.

Authors:  Jonathan O Speare; Danielle K Offerdahl; Aaron Hasenkrug; Aaron B Carmody; Gerald S Baron
Journal:  EMBO J       Date:  2010-01-07       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.